IL22 and chronic mucocutaneous candidiasis: Chronic mucocutaneous candidiasis (CMC) is a monogenetic immunodeficiency of cell-mediated immunity that develops as a consequence of defects in IL-17 and IL-22 immunity required for defence against fungal infections [43].